SG Americas Securities LLC Purchases New Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

SG Americas Securities LLC purchased a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,636 shares of the company’s stock, valued at approximately $120,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in Establishment Labs by 5.2% in the third quarter. Vanguard Group Inc. now owns 71,280 shares of the company’s stock valued at $3,498,000 after purchasing an additional 3,523 shares during the last quarter. American Century Companies Inc. lifted its holdings in Establishment Labs by 1.4% during the 3rd quarter. American Century Companies Inc. now owns 282,292 shares of the company’s stock worth $13,852,000 after buying an additional 3,831 shares during the last quarter. Baker Avenue Asset Management LP bought a new position in Establishment Labs during the 3rd quarter worth approximately $59,000. Kennedy Capital Management LLC lifted its holdings in Establishment Labs by 16.3% during the 3rd quarter. Kennedy Capital Management LLC now owns 139,332 shares of the company’s stock worth $6,837,000 after buying an additional 19,529 shares during the last quarter. Finally, Legal & General Group Plc lifted its holdings in Establishment Labs by 14.3% during the 3rd quarter. Legal & General Group Plc now owns 15,219 shares of the company’s stock worth $747,000 after buying an additional 1,902 shares during the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Up 0.8 %

Shares of Establishment Labs stock opened at $52.57 on Friday. The company has a current ratio of 3.06, a quick ratio of 1.67 and a debt-to-equity ratio of 10.26. The business’s 50 day simple moving average is $46.65 and its 200-day simple moving average is $36.20. The stock has a market capitalization of $1.44 billion, a price-to-earnings ratio of -17.29 and a beta of 1.24. Establishment Labs Holdings Inc. has a twelve month low of $16.96 and a twelve month high of $77.55.

Establishment Labs (NASDAQ:ESTA) last posted its earnings results on Wednesday, February 28th. The company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.95) by $0.16. Establishment Labs had a negative return on equity of 357.81% and a negative net margin of 47.53%. The firm had revenue of $31.60 million for the quarter, compared to analysts’ expectations of $31.44 million. During the same period last year, the firm earned ($0.55) EPS. The firm’s revenue was down 27.9% compared to the same quarter last year. Equities research analysts forecast that Establishment Labs Holdings Inc. will post -1.58 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have commented on ESTA. Citigroup increased their target price on Establishment Labs from $49.00 to $60.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. JPMorgan Chase & Co. increased their target price on Establishment Labs from $46.00 to $53.00 and gave the stock an “overweight” rating in a report on Thursday, February 29th. Mizuho increased their price target on Establishment Labs from $50.00 to $65.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. Finally, Stephens reiterated an “overweight” rating and set a $47.00 price target on shares of Establishment Labs in a research report on Thursday, January 11th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Establishment Labs presently has an average rating of “Buy” and an average target price of $55.00.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.